Trasylol Side Effects Could Result In Kidney Failure Lawsuits
Trasylol Side Effects Injury Lawsuits. The Trasylol injury lawyers at our firm are currently investigating instances where heart surgery patients died after being treated with Trasylol. Since the Bayer AG drug was brought to market in 1993, it has been used in a third of all open heart surgeries in the US. However, numerous studies … [Read more...]
Bayer Settling Trasylol Lawsuits
Bayer Trasylol Lawsuits. About 150 Trasylol lawsuits have been settled by Bayer AG for at least $60 million, according to Bloomberg News. According to three anonymous sources, the settlements provide an average payout of about $400,000 per patient, the report said. Recluse By that time, ‘Trasylol’ had been used in a third of all … [Read more...]
Bayer Failed to Warn of Side Effects
Trasylol Lawsuit Claims Bayer has been sued over Trasylol, a drug used to prevent bleeding during heart bypass surgery that was withdrawn from the market in May 2008. According to MadisonRecord.com, the lawsuit alleges that Bayer did not warn of the possible serious side effects linked to ‘Trasylol’. Trasylol was approved by the … [Read more...]
Trasylol Two Lawsuits
Trasylol Named in Two Lawsuits. Trasylol, Bayer AG's now-withdrawn anti-bleeding medication, is the subject in two Illinois lawsuits. One of the plaintiffs claims Trasylol was the cause of her husband's death, and the other alleges the drug caused him to suffer acute renal failure. Bayer permanently withdrew Trasylol from the … [Read more...]
Trasylol Named in 78 Lawsuits
Trasylol Named in 78 Lawsuits. Bayer AG has been hit with 78 lawsuits over the drug Trasylol. In November, Bayer suspended Trasylol sales after a Canadian study linked it to a higher risk of death. Trayslol was approved in 1993, and was used to prevent bleeding during open heart surgeries. Since its approval, about a third of … [Read more...]
Trasylol Studies Confirm Death Risks
Trasylol Studies Confirm Death Risks. Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug. Trasylol, manufactured by Bayer AG, was the subject of several Food & Drug Administration (FDA) safety reviews before it was finally pulled from the market last … [Read more...]
Trasylol Drug Combo Linked to Deaths
Drug Combo Linked to Deaths A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate. According to British researchers, while use of the clotting drug aprotinin—known as Trasylol—appears safe during on-pump cardiac surgeries, it appears that combining it with … [Read more...]
Trasylol Sales Suspended After Drug Linked to Sudden Death Risk
Trasylol Sales Suspended. Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a risk of sudden death. According to the Food & Drug Administration, Trasylol may have been responsible for more than 200 fatalities. The Canadian Data … [Read more...]
Trasylol Pulled From World Market
Trasylol Pulled From World Market. Trasylol, an anti-bleeding medication, was pulled from the market earlier this week following concerns that it put patients at a high risk of death. The German pharmaceutical firm Bayer AG announced that it would stop worldwide sales of Trasylol after a Canadian ‘Trasylol’ study was suspended … [Read more...]
Death rate higher in patients who are given aprotinin
Patients Who Used Aprotinin In Heart Surgery Are At Risk Of Dying. Patients who are given a widely used drug to prevent excessive bleeding during heart surgery are at increased risk of dying within five years following their operations, medical researchers have found in the largest study of its kind. Results from an international … [Read more...]
FDA Approves New Warning for Bayer Drug
Government health officials said Friday they have approved a new label for Bayer's Trasylol that highlights the possible risk of kidney damage associated with taking the drug. More than 600,000 people worldwide were treated with the drug in 2005, according to Bayer, which collected $291 million in sales from Trasylol. Annual … [Read more...]
